LMR Partners’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

LMR Partners’s Portfolio GRCL Stock Details GRCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-510,001	Closed	-$3.31M	–	1377
2023 Q4	$3.31M	Buy	510,001 +25,485	+5%	+$116K	0.04%	398
2023 Q3	$874K	Buy	484,516 +314,482	+185%	+$1.15M	0.01%	505
2023 Q2	$648K	Buy	170,034 +84,860	+100%	+$238K	0.01%	467
2023 Q1	$158K	Buy	+85,174	New	+$178K	﹤0.01%	884

LMR Partners's GRCL Position: Q1 2024 in Review

LMR Partners sold out of Gracell Biotechnologies Inc. American Depositary Shares (GRCL) in Q1 2024, closing a stake of 510,001 shares — an estimated $3.31M sold.

LMR Partners first reported a position in GRCL in Q1 2023 and held it in 4 quarters. The position peaked at $3.31M in Q4 2023. 0 funds tracked by Wall St. Rank hold GRCL as of Q1 2024.

LMR Partners reported no remaining Gracell Biotechnologies Inc. American Depositary Shares position as of Q1 2024 after selling out during the quarter.
LMR Partners sold 510,001 Gracell Biotechnologies Inc. American Depositary Shares shares in Q1 2024, an estimated $3.31M.
LMR Partners first reported a position in Gracell Biotechnologies Inc. American Depositary Shares in Q1 2023 and held it in 4 quarters.
LMR Partners's Gracell Biotechnologies Inc. American Depositary Shares position peaked at $3.31M in Q4 2023.
0 funds tracked by Wall St. Rank held Gracell Biotechnologies Inc. American Depositary Shares as of Q1 2024.

Based on LMR Partners's 13F filing for Q1 2024, filed 15 May 2024.